Is This Really Hypertension? How to Deal With It?

Arterial hypertension, medically referred to as *hypertension*, represents one of the most prevalent disorders of the cardiovascular system, affecting a substantial proportion of the global population. This condition is broadly categorized into two distinct forms: **primary (essential) hypertension**, accounting for approximately 90% of all cases, and **secondary hypertension**, which constitutes the remaining 10% and arises as a consequence of underlying medical conditions. The etiology of primary hypertension remains a subject of ongoing scientific investigation, though prevailing hypotheses emphasize a **multifactorial origin**, including **genetic predispositions**, **elevated peripheral vascular resistance** (which necessitates increased cardiac output), and **renal regulatory dysfunctions**—given the kidneys' pivotal role in maintaining sodium-water balance. An alternative theoretical framework suggests that genetically determined hypertension may stem from **chronic overactivity of the renin-angiotensin-aldosterone system (RAAS)**, compelling the kidneys to compensate with heightened effort to stabilize electrolyte concentrations. In contrast, **secondary hypertension** manifests as a comorbid symptom associated with other pathological states, such as: **renal diseases** (e.g., glomerulonephritis, polycystic kidney disease), **endocrine disorders** (e.g., primary hyperaldosteronism, Cushing’s syndrome), **neurological conditions** (e.g., brain tumors, spinal cord injuries), or **cardiovascular anomalies** (e.g., coarctation of the aorta). Additionally, **exogenous factors** contribute to elevated blood pressure, including: **chronic psychological stress**, **sedentary lifestyle**, **pregnancy** (preeclampsia), **pharmacotherapy** (particularly corticosteroids, sympathomimetics, or oral contraceptives), **visceral obesity**, and **exposure to toxic substances**—such as illicit drugs (cocaine, amphetamines), heavy metals (lead, cadmium), or excessive alcohol consumption. The most insidious aspect of arterial hypertension lies in its **asymptomatic or paucisymptomatic progression**, which delays diagnosis and amplifies the risk of complications. While the condition may remain clinically silent for years in many individuals, some patients exhibit **non-specific warning signs**, including: **persistent headaches** (often pulsatile and occipital in nature), **sleep disturbances** (insomnia or frequent awakenings), **heightened irritability**, **rapid fatigability with minimal exertion**, and **transient facial flushing**—particularly noticeable on the face, neck, and upper chest, resulting from capillary vasodilation.

Decelerating the daily pace of life represents both the most effective and the most challenging approach to restoring optimal blood pressure parameters. Chronic occupational haste, combined with continuous exposure to environmental stressors, significantly contributes to the persistence of elevated pressure values. An exceptionally critical—yet frequently overlooked—factor is the quality and duration of sleep. Research confirms that individuals maintaining intensive lifestyles consistently reduce the time allocated for nocturnal recovery, whereas high-quality rest can lower blood pressure by up to 22 mmHg. The systematic implementation of modifications—such as rational obligation scheduling, task delegation, and gradual goal attainment—facilitates the progressive reduction of psychological tension. These measures promote the incremental restoration of bodily homeostasis, which translates into long-term stabilization of circulatory metrics.

Epidemiological evidence suggests that more than one-third of individuals diagnosed with arterial hypertension struggle with excess body weight or obesity. Each additional ten kilograms of body mass has been associated with an elevation in blood pressure readings by as much as twenty millimeters of mercury. Excess adipose tissue within the body promotes the development of vascular dysfunctions, impairing microcirculation and contributing to pathological lipid accumulation within the cardiac muscle. These structural and functional alterations serve as a substrate for persistent dysregulation of blood pressure. Consequently, systematic weight monitoring—coupled with balanced nutrition and regular physical activity—should constitute a cornerstone of preventive strategies for individuals at risk of cardiovascular diseases.

When evaluating the physiological impact of alcohol consumption, one must prioritize a fundamental consideration: contemporary evidence-based guidelines stipulate that daily ethanol intake should be meticulously calibrated according to individual parameters—including biological sex, age, physical activity levels, and body mass index—with an optimal range spanning from ten to thirty grams. Longitudinal epidemiological investigations consistently demonstrate that individuals who consume alcohol in modest yet consistent quantities exhibit a statistically significant reduction in the likelihood of developing arterial hypertension compared to both abstainers and irregular drinkers. However, even marginal exceedance of the recommended dosage may trigger pathophysiological pathways conducive to primary hypertension. Equally critical are the health ramifications associated with other addictive substances, particularly tobacco. Constituents of tobacco smoke—such as polycyclic aromatic hydrocarbons and carbon monoxide—have been definitively identified through meta-analyses of clinical trials and mandatory package warnings as etiologic agents underlying the majority of cardiovascular diseases. Documented complications include malignant respiratory tract neoplasms, acute cerebrovascular incidents, ischemic myocardial damage, and progressive arterial atherosclerosis. Notably, the World Health Organization has classified complete tobacco cessation as the single most effective non-pharmacological intervention for hypertension prevention, surpassing even dietary modifications or increased physical exercise in terms of efficacy.

Consistent physical exercise represents one of the most efficacious strategies for lowering elevated blood pressure, a claim substantiated by extensive scientific research. Engaging in regular physical activity has been demonstrated to facilitate a gradual reduction in blood pressure readings by as much as 10 millimeters of mercury. Nevertheless, individuals contending with cardiovascular disorders must tailor the intensity and nature of their exercise regimens to align with their physiological capacities. In instances where hypertension manifests in a severe form, consultation with a healthcare professional or a certified medical fitness trainer becomes indispensable to devise a personalized activity plan. It is noteworthy that well-managed hypertension does not preclude participation in resistance training, though medical advice should always be sought as a precautionary measure. Aerobic exercises characterized by moderate intensity but prolonged duration—such as brisk walking, swimming, or cycling—are particularly advantageous for most patients. Membership in a gym facility is not a prerequisite; daily outdoor walks or structured home-based calisthenics routines can yield comparable benefits. The cornerstone of achieving sustainable results lies in maintaining consistency and embedding physical activity as an enduring component of a health-conscious lifestyle.

Dietary guidelines for hypertension are often focused on weight loss in obese patients. But how should nutrition be tailored when a hypertensive patient already has a normal body weight? In such instances, subclinical micronutrient or vitamin deficiencies frequently contribute to cardiovascular dysfunction. Targeted nutritional adjustments are therefore essential. Emphasizing foods rich in dietary antioxidants—particularly polyphenols and flavonoids that counteract oxidative stress and protect vascular endothelial function—is highly beneficial. Beyond abundant vegetables and fruits, moderate inclusion of polyphenol-rich sources like resveratrol, as well as herbal extracts from aronia (chokeberry), hawthorn flower, Ginkgo biloba, and chamomile, can provide therapeutic vascular support. Optimizing vitamins C and E, coenzyme Q10, and garlic intake is also recommended; garlic exerts proven hypotensive effects and impedes atherogenic vascular remodeling. Two additional dietary components are critical: dietary fiber, which supports cardiometabolic health and reduces cardiovascular disease risk, and magnesium, an essential mineral whose deficiency predisposes to arrhythmias and arterial stiffness. Magnesium should be replenished from nutrient-dense whole foods like white beans, almonds, wheat bran, and pumpkin seeds. Crucially, dietary sodium must be restricted (limiting sodium to under 2.3 g daily, equivalent to under 6 g of table salt) while increasing potassium intake (aiming for up to 4 g daily from plant foods). Potassium directly antagonizes sodium retention, relaxes vascular smooth muscle, and supports myocardial rhythm. Finally, lipid quality must be optimized: replacing saturated animal fats with extra virgin olive oil, cold-pressed seed oils, nuts, and omega-3-rich fatty fish reduces atherogenic lipoproteins and lowers cardiovascular strain.

Hypertension, a condition that in the vast majority of cases progresses asymptomatically over prolonged periods, necessitates consistent health monitoring through structured diagnostic evaluations. Conducting a comprehensive suite of medical examinations not only facilitates the early detection of the disease at its incipient stages but also enables the precise tailoring of therapeutic interventions, thereby significantly enhancing the likelihood of effectively arresting its progression. The prompt identification of severe hypertensive states permits the immediate initiation of targeted treatment regimens, substantially mitigating the risk of life-threatening complications—among which chronic renal insufficiency, cardiac muscle dysfunction (including acute coronary syndromes that may culminate in myocardial infarction), and severe neurological disorders such as ischemic cerebrovascular accidents or dementia syndromes are particularly noteworthy. The diagnostic workflow should incorporate a meticulously obtained patient history, a thorough physical examination (encompassing both visual and tactile assessments), and—above all—the conventional measurement of arterial blood pressure. Historically performed using a stethoscope and manual sphygmomanometer, this procedure has increasingly been supplemented by digital automated devices that empower patients to conduct self-monitoring in home settings, thereby obviating the need for frequent clinical visits. In addition to core diagnostic procedures, a battery of supplementary investigations is strongly advised to not only streamline the detection of hypertension but also to differentiate it from other conditions presenting with analogous clinical manifestations. The most critical of these include: – a complete blood count (CBC) with differential, – fasting plasma glucose level assessment, – serum electrolyte panel (with particular emphasis on sodium and potassium concentrations), – comprehensive lipid profile analysis, – urinalysis with microscopic examination of sediment, – resting electrocardiography (ECG), – echocardiographic evaluation (cardiac ultrasound), – fundoscopic examination (retinal assessment for vascular abnormalities), – chest X-ray (thoracic radiography), – abdominal and carotid artery ultrasonography (to evaluate potential atherosclerotic alterations).

Arterial hypertension represents a significant cardiovascular condition whose progressive nature frequently necessitates the implementation of systematic pharmacological intervention. Pharmaceutical agents designed to lower blood pressure values and mitigate the risk of associated cardiometabolic complications are collectively categorized as antihypertensive medications. Within contemporary cardiological practice, multiple pivotal therapeutic classes are recognized, among which angiotensin-converting enzyme inhibitors (commonly abbreviated as ACE inhibitors) occupy a preeminent position due to their demonstrated efficacy and widespread prescription. Equally integral to hypertension management protocols are calcium channel blockers, beta-adrenoreceptor antagonists (colloquially referred to as beta-blockers), and angiotensin II receptor blockers—more widely known as sartans. Conventional therapeutic approaches typically rely on the concurrent administration of at least two active substances from these categories to achieve a synergistic hypotensive effect. An indispensable component of effective pharmacotherapy furthermore encompasses routine monitoring of circulatory parameters alongside periodic patient assessments to facilitate dosage adjustments or potential modifications to the treatment regimen.